Naiara Naiana Dejani
University of São Paulo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Naiara Naiana Dejani.
Immunobiology | 2014
Naiara Naiana Dejani; Laís Cristina de Souza; Sandra Regina Pereira de Oliveira; Débora Meira Neris; Joice Margareth de Almeida Rodolpho; Ricardo de Oliveira Correia; Vanderlei Rodrigues; Luis Vitor Silva do Sacramento; Lúcia Helena Faccioli; Ana Afonso; Fernanda de Freitas Anibal
Schistosomiasis is a chronic disease caused by an intravascular trematode of the genus Schistosoma. Praziquantel is the drug used for treatment of schistosomiasis; nevertheless failure of treatment has been reported. Consequently, the identification of new effective schistosomicidal compounds is essential to ensure the effective control of schistosomiasis in the future. In this work we investigated the immunomodulatory and antiparasitic effects of the crude leaves extract of Mentha x piperita L. (peppermint) on murine Schistosomiasis mansoni. Female Balb/c mice were infected each with 50 S. mansoni cercariae and divided into three experimental groups: (I) untreated; (II) treated daily with M. x piperita L. (100mg/kg) and III) treated on 1/42/43 days post-infection with Praziquantel (500mg/kg). Another group with uninfected and untreated mice was used as a control. Subsequently, seven weeks post-infection, S. mansoni eggs were counted in the feces, liver and intestine. Worms were recovered by perfusion of the hepatic portal system and counted. Sera levels of IL-10, IL-5, IL-13, IFN-γ, IgG1, IgE and IgG2a were assayed by ELISA. Animals treated with a daily dose of M. x piperita L. showed increased sera levels of IL-10, IFN-γ, IgG2a and IgE. Besides, M. x piperita L. treatment promoted reduction in parasite burden by 35.2% and significant decrease in egg counts in the feces and intestine.
Mediators of Inflammation | 2014
Thais Regina Toledo; Naiara Naiana Dejani; Luis Gustavo Silva Monnazzi; Miriam H. Kossuga; Roberto G. S. Berlinck; Lara Durães Sette; Alexandra I. Medeiros
Very little is known about the immunomodulatory potential of secondary metabolites isolated from marine microorganisms. In the present study, we characterized pyrenocine A, which is produced by the marine-derived fungus Penicillium paxilli Ma(G)K and possesses anti-inflammatory activity. Pyrenocine A was able to suppress, both pretreatment and posttreatment, the LPS-induced activation of macrophages via the inhibition of nitrite production and the synthesis of inflammatory cytokines and PGE2. Pyrenocine A also exhibited anti-inflammatory effects on the expression of receptors directly related to cell migration (Mac-1) as well as costimulatory molecules involved in lymphocyte activation (B7.1). Nitrite production was inhibited by pyrenocine A in macrophages stimulated with CpG but not Poly I:C, suggesting that pyrenocine A acts through the MyD88-dependent intracellular signaling pathway. Moreover, pyrenocine A is also able to inhibit the expression of genes related to NFκB-mediated signal transduction on macrophages stimulated by LPS. Our results indicate that pyrenocine A has promissory anti-inflammatory properties and additional experiments are necessary to confirm this finding in vivo model.
Immunology | 2017
Letícia de Aquino Penteado; Naiara Naiana Dejani; Felipe Fortino Verdan; Allan Botinhon Orlando; Victoria Eugenia Niño; Fernanda De Nuzzi Dias; Ana Carolina Guerta Salina; Alexandra I. Medeiros
Efferocytosis, or clearance of apoptotic cells (ACs), by dendritic cells (DCs) leads to immune response suppression and tolerance to self‐antigens. However, efferocytosis of infected apoptotic cells (IACs) leads to the production of a mixed pro‐ and anti‐inflammatory cytokine milieu. We examined the DC phenotype and ability to migrate after phagocytosis of ACs or IACs and observed higher levels of CD86 and CCR7 expression in DCs, as well as enhanced migration capacity following efferocytosis of IACs. Interestingly, higher levels of interleukin‐1β, interleukin‐10 and prostaglandin E2 (PGE2) were also produced in this context. Blockage of IAC recognition led to an impaired maturation profile and PGE2 production, which may have contributed to reduced CD86 and CCR7 expression and migration capacity. These data contribute to the understanding of how efferocytosis of sterile or infected cells may regulate the adaptive immune response, although the precise role of PGE2 in this process requires further investigation.
PLOS ONE | 2017
Larissa Sbaglia Celiberto; Raquel Bedani; Naiara Naiana Dejani; Alexandra I. Medeiros; José A. Zuanon; Luis Carlos Spolidório; Maria Angela Tallarico Adorno; Maria Bernadete Amâncio Varesche; Fábio Carrilho Galvão; Sandro Roberto Valentini; Graciela Font de Valdez; Elizeu Antonio Rossi; Daniela Cardoso Umbelino Cavallini
Background Some probiotic strains have the potential to assist in relieving the symptoms of inflammatory bowel disease. The impact of daily ingestion of a soy-based product fermented by Enterococcus faecium CRL 183 and Lactobacillus helveticus 416 with the addition of Bifidobacterium longum ATCC 15707 on chemically induced colitis has been investigated thereof within a period of 30 days. Methods Colitis was induced by dextran sulfate sodium. The animals were randomly assigned into five groups: Group C: negative control; Group CL: positive control; Group CLF: DSS with the fermented product; Group CLP: DSS with the non-fermented product (placebo); Group CLS: DSS with sulfasalazine. The following parameters were monitored: disease activity index, fecal microbial analyses, gastrointestinal survival of probiotic microorganisms and short-chain fatty acids concentration in the feces. At the end of the protocol the animals’ colons were removed so as to conduct a macroscopical and histopathological analysis, cytokines and nitrite quantification. Results Animals belonging to the CLF group showed fewer symptoms of colitis during the induction period and a lower degree of inflammation and ulceration in their colon compared to the CL, CLS and CLP groups (p<0.05). The colon of the animals in groups CL and CLS presented severe crypt damage, which was absent in CLF and CLP groups. A significant increase in the population of Lactobacillus spp. and Bifidobacterium spp. at the end of the protocol was verified only in the CLF animals (p<0.05). This group also showed an increase in short-chain fatty acids (propionate and acetate). Furthermore, the intestinal survival of E. faecium CRL 183 and B. longum ATCC 15707 in the CLF group has been confirmed by biochemical and molecular analyzes. Conclusions The obtained results suggest that a regular intake of the probiotic product, and placebo to a lesser extent, can reduce the severity of DSS-induced colitis on rats.
JCI insight | 2018
Stephanie L. Brandt; Sue Wang; Naiara Naiana Dejani; Nathan Klopfenstein; Seth Winfree; Luciano Ribeiro Filgueiras; Brian P. McCarthy; Paul R. Territo; C. Henrique Serezani
Poorly controlled diabetes leads to comorbidities and enhanced susceptibility to infections. While the immune components involved in wound healing in diabetes have been studied, the components involved in susceptibility to skin infections remain unclear. Here, we examined the effects of the inflammatory lipid mediator leukotriene B4 (LTB4) signaling through its receptor B leukotriene receptor 1 (BLT1) in the progression of methicillin-resistant Staphylococcus aureus (MRSA) skin infection in 2 models of diabetes. Diabetic mice produced higher levels of LTB4 in the skin, which correlated with larger nonhealing lesion areas and increased bacterial loads compared with nondiabetic mice. High LTB4 levels were also associated with dysregulated cytokine and chemokine production, excessive neutrophil migration but impaired abscess formation, and uncontrolled collagen deposition. Both genetic deletion and topical pharmacological BLT1 antagonism restored inflammatory response and abscess formation, followed by a reduction in the bacterial load and lesion area in the diabetic mice. Macrophage depletion in diabetic mice limited LTB4 production and improved abscess architecture and skin host defense. These data demonstrate that exaggerated LTB4/BLT1 responses mediate a derailed inflammatory milieu that underlies poor host defense in diabetes. Prevention of LTB4 production/actions could provide a new therapeutic strategy to restore host defense in diabetes.
Mediators of Inflammation | 2016
Lílian Cataldi Rodrigues; Adriana Secatto; Carlos A. Sorgi; Naiara Naiana Dejani; Alexandra I. Medeiros; Morgana Kelly Borges Prado; Simone G. Ramos; Richard D. Cummings; Sean R. Stowell; Lúcia Helena Faccioli; Marcelo Dias-Baruffi
Histoplasma capsulatum is a dimorphic fungus that develops a yeast-like morphology in hosts tissue, responsible for the pulmonary disease histoplasmosis. The recent increase in the incidence of histoplasmosis in immunocompromised patients highlights the need of understanding immunological controls of fungal infections. Here, we describe our discovery of the role of endogenous galectin-1 (Gal-1) in the immune pathophysiology of experimental histoplasmosis. All infected wild-type (WT) mice survived while only 1/3 of Lgals1−/− mice genetically deficient in Gal-1 survived 30 days after infection. Although infected Lgals1−/− mice had increased proinflammatory cytokines, nitric oxide (NO), and elevations in neutrophil pulmonary infiltration, they presented higher fungal load in lungs and spleen. Infected lung and infected macrophages from Lgals1−/− mice exhibited elevated levels of prostaglandin E2 (PGE2, a prostanoid regulator of macrophage activation) and prostaglandin E synthase 2 (Ptgs2) mRNA. Gal-1 did not bind to cell surface of yeast phase of H. capsulatum, in vitro, suggesting that Gal-1 contributed to phagocytes response to infection rather than directly killing the yeast. The data provides the first demonstration of endogenous Gal-1 in the protective immune response against H. capsulatum associated with NO and PGE2 as an important lipid mediator in the pathogenesis of histoplasmosis.
Proceedings of the National Academy of Sciences of the United States of America | 2018
Naiara Naiana Dejani; Allan Botinhon Orlando; Victoria Eugenia Niño; Letícia de Aquino Penteado; Felipe Fortino Verdan; Júlia Miranda Ribeiro Bazzano; Ana Campos Codo; Ana Carolina Guerta Salina; Amanda Correia Saraiva; Matheus Rossi Avelar; Luis Carlos Spolidório; C. Henrique Serezani; Alexandra I. Medeiros
Significance Citrobacter rodentium infection, a murine colitis model to study human intestinal diseases, causes exacerbated apoptosis of intestinal epithelial cells and triggers Th17 immune responses. Here, we identified a heretofore unknown role for the bioactive lipid mediator prostaglandin E2 (PGE2) in the inhibition of Th17 cell differentiation during intestinal C. rodentium infection. When the PGE2 receptor EP4 was antagonized, we detected enhanced colonic Th17 cells, increased expression of antimicrobial peptides, and decreased bacterial numbers in the colon. These results suggest that pharmacological intervention of the PGE2 signaling may be an important target to enhance Th17 actions and improve intestinal host defense. Inflammatory responses are terminated by the clearance of dead cells, a process termed efferocytosis. A consequence of efferocytosis is the synthesis of the antiinflammatory mediators TGF-β, PGE2, and IL-10; however, the efferocytosis of infected cells favors Th17 responses by eliciting the synthesis of TGF-β, IL-6, and IL-23. Recently, we showed that the efferocytosis of apoptotic Escherichia coli-infected macrophages by dendritic cells triggers PGE2 production in addition to pro-Th17 cytokine expression. We therefore examined the role of PGE2 during Th17 differentiation and intestinal pathology. The efferocytosis of apoptotic E. coli-infected cells by dendritic cells promoted high levels of PGE2, which impaired IL-1R expression via the EP4-PKA pathway in T cells and consequently inhibited Th17 differentiation. The outcome of murine intestinal Citrobacter rodentium infection was dependent on the EP4 receptor. Infected mice treated with EP4 antagonist showed enhanced intestinal defense against C. rodentium compared with infected mice treated with vehicle control. Those results suggest that EP4 signaling during infectious colitis could be targeted as a way to enhance Th17 immunity and host defense.
Mediators of Inflammation | 2016
Lílian Cataldi Rodrigues; Adriana Secatto; Carlos A. Sorgi; Naiara Naiana Dejani; Alexandra I. Medeiros; Morgana Kelly Borges Prado; Simone G. Ramos; Richard D. Cummings; Sean R. Stowell; Lúcia Helena Faccioli; Marcelo Dias-Baruffi
Journal of Basic and Applied Pharmaceutical Sciencies | 2016
Letícia de Aquino Penteado; Naiara Naiana Dejani; Fernanda De Nuzzi Dias; Felipe Fortino Verdan; Alexandra I. Medeiros
Journal of Basic and Applied Pharmaceutical Sciencies | 2016
Júlia Miranda Ribeiro Bazzano; Naiara Naiana Dejani; Victoria Eugenia Niño; Alexandra I. Medeiros